Takeda Pharmaceutical Company Limited Gains On Change In Fair Value Of Derivatives
Takeda Pharmaceutical Company Limited (TAK) reported Gains On Change In Fair Value Of Derivatives of JPY 0 for the 12-month period ending 2022-03-31, per its 20-F filed 2022-06-29.
Discontinued › Income Statement › Other Income
ifrs-full:GainsOnChangeInFairValueOfDerivatives · last filed 2022-06-29
| Period end | Gains On Change In Fair Value Of Derivatives 12 month |
|---|---|
| 2022-03-31 | 0.00 JPY 20-F · filed 2022-06-29 |
| 2021-03-31 | 91.99B JPY 20-F · filed 2022-06-29 |
| 2020-03-31 | 0.00 JPY 20-F · filed 2022-06-29 |
| 2019-03-31 | 0.00 JPY 20-F · filed 2021-06-29 |